EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CMR ‐derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis

Christina Kronberger iD, Katharina Mascherbauer iD, Michael Poledniczek iD, Lena Marie Schmid, Carolina Donà, Matthias Koschutnik iD, Laura Lunzer, René Rettl, Franz Duca, Christina Binder, Christian Nitsche, Nikita Ermolaev und 9 weitere

European Journal of Clinical Investigation · 2026-04 · 56 (4)

DOI: 10.1111/eci.70191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 30.03.2026. Verfasst von Christina Kronberger und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Amyloidosis, Cardiomyopathies, Muscle, Skeletal. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cardiac amyloidosis (CA) is a progressive cardiomyopathy caused by amyloid deposition, leading to heart failure and increased mortality. Cardiac magnetic resonance (CMR) identifies myocardial involvement via elevated native T1 relaxation time and extracellular volume (ECV). Although amyloid infiltration has also been observed in thoracic skeletal muscle, the diagnostic and prognostic relevance of thoracic skeletal muscle T1 time and ECV remain unclear.

Aim

To compare native thoracic skeletal muscle T1 time and ECV between CA patients and controls and assess their diagnostic and prognostic value.

Methods

In a prospective CMR registry, consecutive CA patients and controls underwent CMR with T1‐mapping. Native and post‐contrast T1 relaxation time and ECV were quantified in myocardium and thoracic skeletal muscles. Diagnostic performance was evaluated using ROC analysis and associations with mortality were assessed using Cox regression.

Results

Among 1976 participants (267 CA, 1709 controls), CA patients showed significantly higher native myocardial T1 time and ECV, as well as elevated native thoracic skeletal muscle T1 time (919.4 vs. 868.5 ms, p < 0.001) and ECV (16.4 vs. 12.9%, p < 0.001). Native thoracic skeletal muscle T1 time demonstrated moderate diagnostic performance for CA (AUC = 0.70), with an optimal cutoff of 895 ms yielding a sensitivity of 61% and specificity of 59%. Higher native thoracic skeletal muscle T1 time predicted increased mortality (HR = 1.65 per 100 ms, p < 0.001), and this association remained significant after adjusting for age, sex and ventricular function (HR = 1.21 per 100 ms, p = 0.008).

Conclusion

Native skeletal muscle T1 relaxation time and ECV indicate systemic amyloid involvement and provide additional diagnostic and prognostic information beyond myocardial assessment, potentially supporting improved detection and risk stratification in CA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidosisCardiomyopathiesMuscle, SkeletalHumansFemaleMaleMagnetic Resonance ImagingMiddle AgedAgedProspective StudiesMyocardiumCase-Control StudiesPrognosisROC Curve

Stichwörter der Autor:innen

ECVT1‐mappingcardiac amyloidosisdiagnosisnative T1 time

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
  • Division of Cardiovascular and Interventional Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Karl Landsteiner University of Health Sciences, Department of Internal Medicine 3, University Hospital St. Pölten, Krems, Austria.

ORCID-Profile: Christina Kronberger, Katharina Mascherbauer, Michael Poledniczek, Matthias Koschutnik, Varius Dannenberg

Zitieren

APA

Kronberger, C., Mascherbauer, K., Poledniczek, M., Schmid, L. M., Donà, C., Koschutnik, M., Lunzer, L., Rettl, R., Duca, F., Binder, C., Nitsche, C., Ermolaev, N., Celebi, G., Dannenberg, V., Beitzke, D., Badr Eslam, R., Bergler-Klein, J., Mascherbauer, J., Kastner, J., …, & Kammerlander, A. A. (2026). CMR ‐derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis. European Journal of Clinical Investigation, 56(4). https://doi.org/10.1111/eci.70191

Vancouver

Kronberger C, Mascherbauer K, Poledniczek M, Schmid LM, Donà C, Koschutnik M, et al. CMR ‐derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis. European Journal of Clinical Investigation. 2026;56(4). doi:10.1111/eci.70191

BibTeX
@article{Kronberger2026,
  author = {Kronberger, Christina and Mascherbauer, Katharina and Poledniczek, Michael and Schmid, Lena Marie and Donà, Carolina and Koschutnik, Matthias and Lunzer, Laura and Rettl, René and Duca, Franz and Binder, Christina and Nitsche, Christian and Ermolaev, Nikita and Celebi, Gözde and Dannenberg, Varius and Beitzke, Dietrich and Badr Eslam, Roza and Bergler-Klein, Jutta and Mascherbauer, Julia and Kastner, Johannes and Hengstenberg, Christian and Kammerlander, Andreas Anselm},
  title = {CMR ‐derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis},
  journal = {European Journal of Clinical Investigation},
  year = {2026},
  volume = {56},
  number = {4},
  doi = {10.1111/eci.70191}
}
Kostenlos starten →